Atlas Trials

Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)

Clinical trial NCT05322889 · COMPLETED

Trial details

NCT number
NCT05322889
Sponsor
Dr. Frank Behrens
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuropathic PainChemotherapy Effect
Start date
2020-04-09
Primary completion
2022-10-04
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.